Los agonistas del receptor del GLP-1: un abordaje terapéutico eficaz de amplio espectro en el tratamiento de la diabetes mellitus tipo 2
Leído
425
Vecesse ha leído el artículo
164
Total PDF
261
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 5 | 0 | 1 | 1 |
| 2023 12 | 0 | 2 | 2 |
| 2023 3 | 3 | 3 | 6 |
| 2017 12 | 1 | 0 | 1 |
| 2017 10 | 4 | 3 | 7 |
| 2017 9 | 3 | 12 | 15 |
| 2017 8 | 3 | 3 | 6 |
| 2017 7 | 12 | 4 | 16 |
| 2017 6 | 12 | 17 | 29 |
| 2017 5 | 13 | 1 | 14 |
| 2017 4 | 16 | 3 | 19 |
| 2017 3 | 21 | 44 | 65 |
| 2017 2 | 11 | 4 | 15 |
| 2016 1 | 6 | 2 | 8 |
| 2016 12 | 21 | 11 | 32 |
| 2016 11 | 27 | 10 | 37 |
| 2016 10 | 45 | 16 | 61 |
| 2016 9 | 54 | 14 | 68 |
| 2016 8 | 7 | 3 | 10 |
| 2016 3 | 1 | 2 | 3 |
| 2016 2 | 0 | 1 | 1 |
| 2015 6 | 0 | 1 | 1 |
| 2015 5 | 1 | 1 | 2 |
| 2015 3 | 0 | 1 | 1 |
| 2015 1 | 0 | 2 | 2 |
| 2014 12 | 0 | 2 | 2 |
| 2014 11 | 0 | 1 | 1 |
Mostrar todo
